MYOTONIC DYSTROPHY
Clinical trials for MYOTONIC DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new MYOTONIC DYSTROPHY trials appear
Sign up with your email to follow new studies for MYOTONIC DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to control debilitating muscle disease
Disease control OngoingThis global Phase 3 trial is testing whether an intravenous drug called AOC 1001 can help control symptoms of myotonic dystrophy type 1, a genetic muscle-wasting disease. About 159 adults with a confirmed diagnosis will receive either the drug or a placebo via infusion every 8 we…
Matched conditions: MYOTONIC DYSTROPHY
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Four-Year trial tests potential new treatment for debilitating muscle disease
Disease control ENROLLING_BY_INVITATIONThis study is testing the long-term safety and effectiveness of an investigational drug called del-desiran for adults with myotonic dystrophy type 1 (DM1), a genetic muscle-wasting disease. Participants who completed a previous related study will receive an intravenous infusion o…
Matched conditions: MYOTONIC DYSTROPHY
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New test aims to stop dangerous falls for people with Muscle-Weakening diseases
Diagnosis ENROLLING_BY_INVITATIONThis study aims to create and validate a simple set of physical tests to better predict the risk of falling for people with various nerve and muscle disorders. Researchers will test 108 patients with conditions like muscular dystrophy and ALS using tasks like standing up from a c…
Matched conditions: MYOTONIC DYSTROPHY
Sponsor: LMU Klinikum • Aim: Diagnosis
Last updated Mar 20, 2026 14:47 UTC
-
Extended trial tests daily pill to ease debilitating muscle locking
Symptom relief ENROLLING_BY_INVITATIONThis study is following up on a previous trial to see how safe and helpful a daily medication called mexiletine is over a longer period for people with myotonic dystrophy types 1 and 2. It involves about 176 adults who have already finished the earlier study. Everyone in this new…
Matched conditions: MYOTONIC DYSTROPHY
Phase: PHASE3 • Sponsor: Lupin Ltd. • Aim: Symptom relief
Last updated Mar 06, 2026 15:37 UTC